Transcriptome analysis reveals a classical interferon signature induced by IFNλ4 in human primary cells. (Q40844750)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26066369%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

title

Transcriptome analysis reveals a classical interferon signature induced by IFNλ4 in human primary cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26066369%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

0 references

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26066369%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Ronald Dijkman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26066369%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Hans Henrik Gad

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26066369%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Volker Thiel

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26066369%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Lars Kaderali

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26066369%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

author name string

C Lauber

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26066369%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

G Vieyres

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26066369%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

E Terczyńska-Dyla

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26066369%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Anggakusuma

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26066369%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

H Akhtar

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26066369%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

R Geffers

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26066369%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

F W R Vondran

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26066369%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

T Pietschmann

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26066369%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

publication date

11 June 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26066369%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26066369%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26066369%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26066369%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

page(s)

414-421

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26066369%20AND%20SRC:MED&resulttype=core&format=json

The type I interferon receptor: structure, function, and evolution of a family business.

17 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2015.23

How cells respond to interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2015.23

IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2015.23

IL-28, IL-29 and their class II cytokine receptor IL-28R

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2015.23

Human but not mouse hepatocytes respond to interferon-lambda in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2015.23

IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2015.23

Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2015.23

Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2015.23

Type III interferon (IFN) induces a type I IFN-like response in a restricted subset of cells through signaling pathways involving both the Jak-STAT pathway and the mitogen-activated protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2015.23

Dynamic expression profiling of type I and type III interferon-stimulated hepatocytes reveals a stable hierarchy of gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2015.23

Kinetic differences in the induction of interferon stimulated genes by interferon-α and interleukin 28B are altered by infection with hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2015.23

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2015.23

Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2015.23

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2015.23

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2015.23

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2015.23

A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2015.23

Interferon lambda 4 signals via the IFNλ receptor to regulate antiviral activity against HCV and coronaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2015.23

IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2015.23

Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2015.23

The IFNL3/4 ΔG variant increases susceptibility to cytomegalovirus retinitis among HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2015.23

Influence of IFNL3/4 polymorphisms on the incidence of cytomegalovirus infection after solid-organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2015.23

Explanted diseased livers - a possible source of metabolic competent primary human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2015.23

Isolation and characterization of current human coronavirus strains in primary human epithelial cell cultures reveal differences in target cell tropism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2015.23

Interferome v2.0: an updated database of annotated interferon-regulated genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2015.23

Cloning of a new type II cytokine receptor activating signal transducer and activator of transcription (STAT)1, STAT2 and STAT3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2015.23

Despite IFN-lambda receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2015.23

IFN-λ receptor 1 expression is induced in chronic hepatitis C and correlates with the IFN-λ3 genotype and with nonresponsiveness to IFN-α therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2015.23

The soluble murine type I interferon receptor Ifnar-2 is present in serum, is independently regulated, and has both agonistic and antagonistic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2015.23

IL-22 from conventional NK cells is epithelial regenerative and inflammation protective during influenza infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2015.23

RNA-Seq: a revolutionary tool for transcriptomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2015.23

Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2015.23

IFN-lambda determines the intestinal epithelial antiviral host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2015.23

Association of the IFNL4-ΔG Allele With Impaired Spontaneous Clearance of Hepatitis C Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2015.23

Human interferon-lambda3 is a potent member of the type III interferon family.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2015.23

TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2015.23

Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2015.23

HTSeq--a Python framework to work with high-throughput sequencing data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2015.23

Differential expression analysis for sequence count data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2015.23

edgeR: a Bioconductor package for differential expression analysis of digital gene expression data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2015.23

voom: Precision weights unlock linear model analysis tools for RNA-seq read counts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2015.23

Calculating sample size estimates for RNA sequencing data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2015.23

Rapid and simple detection of IFN-neutralizing antibodies in chronic hepatitis C non-responsive to IFN-α

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGENE.2015.23

Mutant U5A cells are complemented by an interferon-alpha beta receptor subunit generated by alternative processing of a new member of a cytokine receptor gene cluster

21 January 2018

1 reference

12 December 2020

The short form of the interferon alpha/beta receptor chain 2 acts as a dominant negative for type I interferon action

1 reference

12 December 2020

The relative endogenous expression levels of the IFNAR2 isoforms influence the cytostatic and pro-apoptotic effect of IFNalpha on pleomorphic sarcoma cells

1 reference

12 December 2020

Loss of function of the new interferon IFN-λ4 may confer protection from hepatitis C

1 reference

12 December 2020